SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,759,487 | +45959.9% | 85,495 | +5.2% | 0.11% | -50.7% |
| Q2 2023 | $3,820 | +25.1% | 81,233 | +11.6% | 0.23% | +21.4% |
| Q1 2023 | $3,053 | +12.7% | 72,757 | +2.5% | 0.19% | +12.0% |
| Q4 2022 | $2,709 | -99.9% | 71,017 | -11.7% | 0.17% | -19.3% |
| Q3 2022 | $3,148,000 | +24.3% | 80,390 | +2.5% | 0.21% | +31.8% |
| Q2 2022 | $2,533,000 | +22.4% | 78,418 | +25.4% | 0.16% | +42.7% |
| Q1 2022 | $2,070,000 | -6.9% | 62,552 | +19.6% | 0.11% | +0.9% |
| Q4 2021 | $2,224,000 | +32.5% | 52,288 | +38.0% | 0.11% | +23.9% |
| Q3 2021 | $1,679,000 | -23.7% | 37,895 | -2.2% | 0.09% | -24.8% |
| Q2 2021 | $2,200,000 | -24.9% | 38,730 | -1.1% | 0.12% | -33.5% |
| Q1 2021 | $2,930,000 | – | 39,151 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |